VNET Group (VNET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SelectQuote (SLQT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ZURICH , Aug. 14, 2025 /PRNewswire/ -- The Board of Directors of Chubb Limited (NYSE: CB) today declared a quarterly dividend equal to $0.97 per share, payable on October 3, 2025 to shareholders of record at the close of business on September 12, 2025. The dividend will be payable out of legal reserves and will be made in United States dollars by the company's transfer agent, as described in the Chubb Limited 2025 proxy statement.

The company is evolving from a Telecom and Technology business into a Global Connectivity & AI Technology Corporation NEW YORK , Aug. 14, 2025 /PRNewswire/ -- IQSTEL Inc. (NASDAQ: IQST) today announced its financial results for the second quarter ended June 30, 2025, reporting substantial growth in shareholder equity, improved gross margins, and increased profitability in its telecom division. Q2 2025 Highlights: Net Shareholder Equity increased from $11.9 million in December 2024 to $14.29 million as of June 30, 2025 — not yet including the benefit of a $3.5 million debt reduction announced in July, expected to be reflected in …

VIPS, LRN, HSBC and FUTU stand out in a low-beta stock screen, offering potential stability in a volatile market backdrop.

After losing some value lately, a hammer chart pattern has been formed for Amarin (AMRN), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

After reaching an important support level, Maximus, Inc. (MMS) could be a good stock pick from a technical perspective. MMS recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.

The mean of analysts' price targets for Syndax (SNDX) points to a 158.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The consensus price target hints at a 41.7% upside potential for Natural Gas Services (NGS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The mean of analysts' price targets for El Pollo Loco (LOCO) points to a 28.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

After reaching an important support level, PHINIA Inc. (PHIN) could be a good stock pick from a technical perspective. PHIN recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.

The average of price targets set by Wall Street analysts indicates a potential upside of 37% in Deluxe (DLX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

XCel Brands (XELB) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.5. This compares to a loss of $0.1 per share a year ago.

Newmark Group, Inc. (NMRK) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, NMRK's 50-day simple moving average crossed above its 200-day simple moving average, known as a "golden cross.

The average of price targets set by Wall Street analysts indicates a potential upside of 44.8% in Arcutis Biotherapeutics (ARQT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The consensus price target hints at an 187.7% upside potential for Bicara Therapeutics Inc. (BCAX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The mean of analysts' price targets for The Beachbody Company (BODI) points to an 114.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 27.7% in Amneal (AMRX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

I rate SKYY a hold due to its strong cloud/A.I. growth prospects but high valuations make me cautious about buying now. SKYY is well-positioned with large-cap cloud leaders and benefits from digital transformation, but its top holdings concentration adds risk. The fund outperforms peers and should deliver double-digit growth, but high multiples mean volatility and sensitivity to interest rates.

Apple announced a redesigned blood oxygen feature is rolling out to some Apple Watch users. The company has been embroiled in a years-long intellectual property dispute with Masimo over the capability.